Obstructive sleep apnea and severity of coronary artery disease

Ali Vasheghani-Farahani1, Fatemeh Kazemnejad2, Khosro Sadeghniiat-Haghighi3

  • 1Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences Tehran, Iran.

Insights

Obstructive sleep apnea (OSA) is independently associated with coronary artery disease (CAD). Increased severity of OSA, measured by the Multivariable apnea prediction (MAP) index, correlated with higher Gensini scores, indicating more severe atherosclerosis.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Vascular Biology

Background:

  • Obstructive sleep apnea (OSA) is linked to cardiovascular diseases like stroke, myocardial infarction, coronary artery disease (CAD), and hypertension.
  • Atherosclerosis is a key contributor to cardiovascular morbidity and mortality.

Purpose of the Study:

  • To investigate the correlation between obstructive sleep apnea (OSA) and the severity of atherosclerosis.
  • To assess the association between OSA and coronary artery disease (CAD) severity using angiography.

Main Methods:

  • 337 patients undergoing coronary angiography were assessed.
  • Obstructive sleep apnea (OSA) was evaluated using the Multivariable apnea prediction (MAP) risk index.
  • Coronary angiograms were scored using the Gensini score to quantify atherosclerosis severity.

Main Results:

  • The prevalence of three-vessel disease was significantly higher in the OSA group (68.0%) compared to the non-OSA group (32.0%).
  • The Multivariable apnea prediction (MAP) index was identified as the most significant independent determinant of the Gensini score.
  • Gensini scores demonstrated a positive correlation with increasing MAP values.

Conclusions:

  • Obstructive sleep apnea (OSA) shows an independent association with coronary artery disease (CAD).
  • OSA should be considered a significant risk factor for CAD, even after accounting for traditional confounders.
  • These findings highlight the importance of evaluating OSA in patients with or at risk for CAD.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
581
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
480
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
276
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
385
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
699